Qure.ai provides AI-powered imaging tools for neurocritical care, focused on intracranial hemorrhage detection and stroke management through qER AI that analyzes head CTs. The qER AI + Qure App delivers real-time alerts, workflow prioritization, and secure data sharing to accelerate diagnosis and coordinated treatment, with qER FDA-cleared for bleeds and the platform CE Class IIb certified. The solution has processed over 8 million scans worldwide, delivering high sensitivity for ICH detection and meaningful reductions in time-to-treatment and activation times.
AI named Qure.ai qER from July 2026 to September 2026.
AI cited qure.ai in these answers, after aidoc.com, documentation.qure.ai, and diabetesjournals.org.
qure.ai/us/product/qer 8%Other sites 92%